• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone

home / publications / supplement / patients-with-diabetes-and-chronic-kidney-disease-ace-inhibitor-or-arb-treatment-medical-costs-f
© 2024 MJH Life Sciences
All rights reserved.